Coramaze Technologies develops the Tripair, a device repairing functional Tricuspid Regurgitation (fTR) in heart failure patients, to improve quality of life and reduce morbidity. The Tripair implant is anchored a-traumatically in the right atrium, enabling full retrievability and intra-procedural efficacy evaluation.
Company’s Keywords:
medical devices, cardiovascular medical technology, transcatheter mitral valve repair, structural heart valve diseases
<15
<3200000
<2013